International Cardiovascular Center Rhein-Ruhr, Essen, Germany.
J Am Soc Echocardiogr. 2011 Mar;24(3):350.e1-4. doi: 10.1016/j.echo.2010.06.007. Epub 2010 Jul 24.
A 68-year-old man was admitted to the hospital 4 months after HeartMate II ventricular assist device implantation, because his clinical status had deteriorated and his levels of lactate dehydrogenase and free hemoglobin had increased. Transthoracic echocardiography performed at admission revealed decreased basic diastolic continuous flow velocity with a pulsatile increase in flow velocity during ventricular contraction in both inflow and outflow cannulas. Twelve hours after beginning lytic therapy, basal diastolic continuous flow velocity had increased, and the amplitude between diastolic and systolic flow velocity had decreased. The clinical status of the patient improved, and his lactate dehydrogenase decreased. A decrease in basal diastolic flow may be a valuable marker of flow disturbance in continuous flow ventricular assist devices.
一位 68 岁男性在植入 HeartMate II 心室辅助装置 4 个月后因临床状况恶化且乳酸脱氢酶和游离血红蛋白水平升高而入院。入院时进行的经胸超声心动图显示,在流入和流出套管中,舒张期基本连续流速降低,收缩期时流速呈搏动性增加。开始溶栓治疗 12 小时后,舒张期基本连续流速增加,舒张期和收缩期流速之间的幅度降低。患者的临床状况改善,乳酸脱氢酶降低。基础舒张期流量减少可能是连续流量心室辅助装置中流量障碍的有价值标志物。